Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  USANA Health Sciences, Inc.    USNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

USANA Health Sciences, Inc. : USANA Schedules First Quarter Earnings Release and Conference Call

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:50pm CET

USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter results will be released after the close of market Tuesday, April 24, 2012. USANA executives will hold a conference call to discuss this announcement with analysts and institutional investors the following morning at 11:00 a.m. Eastern Time.

The call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.

The webcast is also being distributed over Thomson's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson's Individual Investor Network. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

About USANA

USANA develops and manufactures high-quality nutritional, personal care, and weight-management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France and Belgium. Additionally, USANA's wholly owned subsidiary, BabyCare, Ltd., operates a direct selling business in China. More information on USANA can be found at http://www.usanahealthsciences.com.

USANA Health Sciences, Inc.
Patrique Richards, 801-954-7961
Investor Relations
[email protected]


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on USANA HEALTH SCIENCES, INC
11/08 USANA HEALTH SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
10/30 USANA HEALTH SCIENCES : Women's Tennis Association Donates $25,000 USD To USANA ..
10/25 USANA HEALTH SCIENCES, INC. (NYSE : USNA) Files An 8-K Results of Operations and..
10/24 USANA HEALTH SCIENCES : posts 3Q profit
10/24 USANA HEALTH SCIENCES INC : Results of Operations and Financial Condition, Regul..
10/24 USANA HEALTH SCIENCES : Reports Third Quarter Financial Results
10/23 USANA HEALTH SCIENCES : The Dr. Myron Wentz Science Center At North Central Coll..
10/19 USANA HEALTH SCIENCES : Trademark Application for "COQUINONE" Filed by Usana Hea..
10/14 USANA HEALTH SCIENCES : Launches Two New Products in Canada
10/09 USANA HEALTH SCIENCES : Schedules Third Quarter Earnings Release and Conference ..
More news
News from SeekingAlpha
11/01 Magic Formula Investing Companies Vs. The Most Traded Companies In The U.S. M..
10/31 Biggest Winners And Losers This Earnings Season
10/26 Steady Growth With USANA Health Sciences
10/25 USANA Health Sciences' (USNA) CEO Kevin Guest on Q3 2017 Results - Earnings C..
10/24 USANA Health Sciences beats by $0.11, beats on revenue
Financials ($)
Sales 2017 1 033 M
EBIT 2017 139 M
Net income 2017 92,1 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 18,86
P/E ratio 2018 16,41
Capi. / Sales 2017 1,64x
Capi. / Sales 2018 1,55x
Capitalization 1 693 M
Chart USANA HEALTH SCIENCES, INC
Duration : Period :
USANA Health Sciences, Inc Technical Analysis Chart | USNA | US90328M1071 | 4-Traders
Technical analysis trends USANA HEALTH SCIENCES, INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 78,5 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Kevin G. Guest Chief Executive Officer & Director
Jim Brown President & Chief Operating Officer
Myron W. Wentz Chairman
G. Douglas Hekking Chief Financial Officer
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
USANA HEALTH SCIENCES, INC.15.60%1 701
PROCTER & GAMBLE COMPANY7.16%229 265
UNILEVER NV (ADR)39.72%167 922
UNILEVER (NL)25.12%167 889
UNILEVER27.00%167 889
COLGATE-PALMOLIVE COMPANY11.86%64 383